Nuclear Radiopharmaceutical - Global and China Top Players Market Share and Ranking 2023
According to latest Research, the global market for Nuclear Radiopharmaceutical should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Nuclear Radiopharmaceutical market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Nuclear Radiopharmaceutical market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Oncology grew percent to account for percent of the total market sales, and Thyroid grew percent.
Nuclear Radiopharmaceuticals consist primarily of a radioactive isotope that is incorporated into a drug to assess the disease state in the body. The drug is used to deliver the radioactive isotope to an organ, tissue or specific cell in the body.
This report studies and analyses global Nuclear Radiopharmaceutical status and future trends, helps the client to determine the Nuclear Radiopharmaceutical market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Nuclear Radiopharmaceutical, and provides market size (in Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Nuclear Radiopharmaceutical market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (Units)
(2) Global Nuclear Radiopharmaceutical sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Units)
(3) China Nuclear Radiopharmaceutical sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Units)
(4) Global Nuclear Radiopharmaceutical key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Nuclear Radiopharmaceutical key producing regions, capacity, production, and year over year growth
(6) Nuclear Radiopharmaceutical industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Nihon Medi-Physics Co.,Ltd.
Curium Pharma
Cardinal Health
Bayer Global
GE Healthcare
Mallinckrodt Pharmaceuticals
Bracco Group
Advanced Molecular-imaging Solution
China Isotope & Radiation
Ciaeriar
Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
Market segment by Type, covers
Diagnostic
Therapeutic
Market segment by Application, can be divided into
Oncology
Thyroid
Cardiology
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Nuclear Radiopharmaceutical product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Nuclear Radiopharmaceutical market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Nuclear Radiopharmaceutical market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Nuclear Radiopharmaceutical, percent & CAGR, 2018-2029
Chapter 5: Nuclear Radiopharmaceutical industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Nuclear Radiopharmaceutical Definition
1.2 Global Nuclear Radiopharmaceutical Market Size and Forecast
1.2.1 By Consumption Value, Global Nuclear Radiopharmaceutical Market Size，2018-2029
1.2.2 By Sales Quantity, Global Nuclear Radiopharmaceutical Market Size，2018-2029
1.2.3 Global Nuclear Radiopharmaceutical Average Selling Price (ASP)，2018-2029
1.3 China Nuclear Radiopharmaceutical Market Size and Forecast
1.3.1 By Consumption Value, China Nuclear Radiopharmaceutical Market Size，2018-2029
1.3.2 By Sales Quantity, China Nuclear Radiopharmaceutical Market Size，2018-2029
1.3.3 China Nuclear Radiopharmaceutical Average Selling Price (ASP)， 2018-2029
1.4 Share of China Nuclear Radiopharmaceutical Market with Respect to the Global Market
1.4.1 By Consumption Value, China Nuclear Radiopharmaceutical Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Nuclear Radiopharmaceutical Market Share in Global, 2018-2029
1.4.3 Nuclear Radiopharmaceutical Market Size: China VS Global, 2018-2029
1.5 Nuclear Radiopharmaceutical Market Dynamics
1.5.1 Nuclear Radiopharmaceutical Market Drivers
1.5.2 Nuclear Radiopharmaceutical Market Restraints
1.5.3 Nuclear Radiopharmaceutical Industry Trends
1.5.4 Nuclear Radiopharmaceutical Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Nuclear Radiopharmaceutical, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Nuclear Radiopharmaceutical, Global Market Share by Company, 2018-2023
2.3 Nuclear Radiopharmaceutical Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Nuclear Radiopharmaceutical Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Nuclear Radiopharmaceutical Concentration Ratio
2.6 Global Nuclear Radiopharmaceutical Mergers & Acquisitions, Expansion Plans
2.7 Global Nuclear Radiopharmaceutical Manufacturers Product Type
2.8 Head Office and Nuclear Radiopharmaceutical Production Site of Key Manufacturer
2.9 Nuclear Radiopharmaceutical Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Nuclear Radiopharmaceutical, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Nuclear Radiopharmaceutical, China Market Share by Company, 2018-2023
3.3 China Nuclear Radiopharmaceutical Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Nuclear Radiopharmaceutical Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Nuclear Radiopharmaceutical Capacity by Region
4.3 Global Nuclear Radiopharmaceutical Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Nuclear Radiopharmaceutical Production by Region, 2018-2029
4.5 Global Nuclear Radiopharmaceutical Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Nuclear Radiopharmaceutical Industry Chain
5.2 Nuclear Radiopharmaceutical Upstream Analysis
5.2.1 Nuclear Radiopharmaceutical Core Raw Materials
5.2.2 Main Manufacturers of Nuclear Radiopharmaceutical Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Nuclear Radiopharmaceutical Production Mode
5.6 Nuclear Radiopharmaceutical Procurement Model
5.7 Nuclear Radiopharmaceutical Industry Sales Model and Sales Channels
5.7.1 Nuclear Radiopharmaceutical Sales Model
5.7.2 Nuclear Radiopharmaceutical Typical Distributors
6 Sights by Type
6.1 Nuclear Radiopharmaceutical Classification
6.1.1 Diagnostic
6.1.2 Therapeutic
6.2 By Type, Global Nuclear Radiopharmaceutical Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Nuclear Radiopharmaceutical Consumption Value, 2018-2029
6.4 By Type, Global Nuclear Radiopharmaceutical Sales Quantity, 2018-2029
6.5 By Type, Global Nuclear Radiopharmaceutical Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Nuclear Radiopharmaceutical Segment by Application
7.1.1 Oncology
7.1.2 Thyroid
7.1.3 Cardiology
7.1.4 Others
7.2 By Application, Global Nuclear Radiopharmaceutical Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Nuclear Radiopharmaceutical Consumption Value, 2018-2029
7.4 By Application, Global Nuclear Radiopharmaceutical Sales Quantity, 2018-2029
7.5 By Application, Global Nuclear Radiopharmaceutical Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Nuclear Radiopharmaceutical Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Nuclear Radiopharmaceutical Consumption Value, 2018-2029
8.3 By Region, Global Nuclear Radiopharmaceutical Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Nuclear Radiopharmaceutical & Forecasts, 2018-2029
8.4.2 By Country, North America Nuclear Radiopharmaceutical Market Size Market Share
8.5 Europe
8.5.1 Europe Nuclear Radiopharmaceutical Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Nuclear Radiopharmaceutical Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Nuclear Radiopharmaceutical Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Nuclear Radiopharmaceutical Market Size Market Share
8.7 South America
8.7.1 South America Nuclear Radiopharmaceutical Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Nuclear Radiopharmaceutical Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Nuclear Radiopharmaceutical Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Nuclear Radiopharmaceutical Consumption Value, 2018-2029
9.3 By Country, Global Nuclear Radiopharmaceutical Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Nuclear Radiopharmaceutical Market Size, 2018-2029
9.4.2 By Type, U.S. Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Nuclear Radiopharmaceutical Market Size, 2018-2029
9.5.2 By Type, Europe Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Nuclear Radiopharmaceutical Market Size, 2018-2029
9.6.2 By Type, China Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Nuclear Radiopharmaceutical Market Size, 2018-2029
9.7.2 By Type, Japan Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Nuclear Radiopharmaceutical Market Size, 2018-2029
9.8.2 By Type, South Korea Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Nuclear Radiopharmaceutical Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Nuclear Radiopharmaceutical Market Size, 2018-2029
9.10.2 By Type, India Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Nuclear Radiopharmaceutical Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Nihon Medi-Physics Co.,Ltd.
10.1.1 Nihon Medi-Physics Co.,Ltd. Company Information, Head Office, Market Area, and Industry Position
10.1.2 Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Models, Specifications, and Application
10.1.3 Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Nihon Medi-Physics Co.,Ltd. Company Profile and Main Business
10.1.5 Nihon Medi-Physics Co.,Ltd. Recent Developments
10.2 Curium Pharma
10.2.1 Curium Pharma Company Information, Head Office, Market Area, and Industry Position
10.2.2 Curium Pharma Nuclear Radiopharmaceutical Models, Specifications, and Application
10.2.3 Curium Pharma Nuclear Radiopharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Curium Pharma Company Profile and Main Business
10.2.5 Curium Pharma Recent Developments
10.3 Cardinal Health
10.3.1 Cardinal Health Company Information, Head Office, Market Area, and Industry Position
10.3.2 Cardinal Health Nuclear Radiopharmaceutical Models, Specifications, and Application
10.3.3 Cardinal Health Nuclear Radiopharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Cardinal Health Company Profile and Main Business
10.3.5 Cardinal Health Recent Developments
10.4 Bayer Global
10.4.1 Bayer Global Company Information, Head Office, Market Area, and Industry Position
10.4.2 Bayer Global Nuclear Radiopharmaceutical Models, Specifications, and Application
10.4.3 Bayer Global Nuclear Radiopharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Bayer Global Company Profile and Main Business
10.4.5 Bayer Global Recent Developments
10.5 GE Healthcare
10.5.1 GE Healthcare Company Information, Head Office, Market Area, and Industry Position
10.5.2 GE Healthcare Nuclear Radiopharmaceutical Models, Specifications, and Application
10.5.3 GE Healthcare Nuclear Radiopharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 GE Healthcare Company Profile and Main Business
10.5.5 GE Healthcare Recent Developments
10.6 Mallinckrodt Pharmaceuticals
10.6.1 Mallinckrodt Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.6.2 Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Models, Specifications, and Application
10.6.3 Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Mallinckrodt Pharmaceuticals Company Profile and Main Business
10.6.5 Mallinckrodt Pharmaceuticals Recent Developments
10.7 Bracco Group
10.7.1 Bracco Group Company Information, Head Office, Market Area, and Industry Position
10.7.2 Bracco Group Nuclear Radiopharmaceutical Models, Specifications, and Application
10.7.3 Bracco Group Nuclear Radiopharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Bracco Group Company Profile and Main Business
10.7.5 Bracco Group Recent Developments
10.8 Advanced Molecular-imaging Solution
10.8.1 Advanced Molecular-imaging Solution Company Information, Head Office, Market Area, and Industry Position
10.8.2 Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Models, Specifications, and Application
10.8.3 Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Advanced Molecular-imaging Solution Company Profile and Main Business
10.8.5 Advanced Molecular-imaging Solution Recent Developments
10.9 China Isotope & Radiation
10.9.1 China Isotope & Radiation Company Information, Head Office, Market Area, and Industry Position
10.9.2 China Isotope & Radiation Nuclear Radiopharmaceutical Models, Specifications, and Application
10.9.3 China Isotope & Radiation Nuclear Radiopharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 China Isotope & Radiation Company Profile and Main Business
10.9.5 China Isotope & Radiation Recent Developments
10.10 Ciaeriar
10.10.1 Ciaeriar Company Information, Head Office, Market Area, and Industry Position
10.10.2 Ciaeriar Nuclear Radiopharmaceutical Models, Specifications, and Application
10.10.3 Ciaeriar Nuclear Radiopharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Ciaeriar Company Profile and Main Business
10.10.5 Ciaeriar Recent Developments
10.11 Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
10.11.1 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Company Information, Head Office, Market Area, and Industry Position
10.11.2 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Models, Specifications, and Application
10.11.3 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Company Profile and Main Business
10.11.5 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Nuclear Radiopharmaceutical Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Nuclear Radiopharmaceutical Market Restraints
Table 3. Nuclear Radiopharmaceutical Market Trends
Table 4. Nuclear Radiopharmaceutical Industry Policy
Table 5. Global Nuclear Radiopharmaceutical Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Nuclear Radiopharmaceutical Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Nuclear Radiopharmaceutical Sales Quantity by Company, (2018-2023) & (Units), Ranked Based on Sales in 2022
Table 8. Global Nuclear Radiopharmaceutical Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Nuclear Radiopharmaceutical Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Nuclear Radiopharmaceutical Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Nuclear Radiopharmaceutical Mergers & Acquisitions, Expansion Plans
Table 12. Global Nuclear Radiopharmaceutical Manufacturers Product Type
Table 13. Head Office and Nuclear Radiopharmaceutical Production Site of Key Manufacturer
Table 14. Nuclear Radiopharmaceutical Capacity of Major Manufacturers and Future Plan
Table 15. China Nuclear Radiopharmaceutical Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Nuclear Radiopharmaceutical Sales Quantity by Company, (2018-2023) & (Units), Ranked Based on Sales in 2022
Table 17. China Nuclear Radiopharmaceutical Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Nuclear Radiopharmaceutical Production & Forecast by Region, 2018 VS 2022 VS 2029, (Units)
Table 19. Global Nuclear Radiopharmaceutical Production by Region, 2018-2023, (Units)
Table 20. Global Nuclear Radiopharmaceutical Production Forecast by Region, 2024-2029, (Units)
Table 21. Global Key Players of Nuclear Radiopharmaceutical Upstream (Raw Materials)
Table 22. Global Nuclear Radiopharmaceutical Typical Customers
Table 23. Nuclear Radiopharmaceutical Typical Distributors
Table 24. By Type, Global Nuclear Radiopharmaceutical Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Nuclear Radiopharmaceutical Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Nuclear Radiopharmaceutical Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Nuclear Radiopharmaceutical Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Nuclear Radiopharmaceutical Sales Quantity, 2018-2029, (Units)
Table 29. By Country, Global Nuclear Radiopharmaceutical Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Nuclear Radiopharmaceutical Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Nuclear Radiopharmaceutical Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Nuclear Radiopharmaceutical Sales Quantity, 2018-2029, (Units)
Table 33. By Country, Global Nuclear Radiopharmaceutical Sales Quantity Market Share, 2018-2029
Table 34. Nihon Medi-Physics Co.,Ltd. Company Information, Head Office, Market Area, and Industry Position
Table 35. Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Models, Specifications, and Application
Table 36. Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Nihon Medi-Physics Co.,Ltd. Company Profile and Main Business
Table 38. Nihon Medi-Physics Co.,Ltd. Recent Developments
Table 39. Curium Pharma Company Information, Head Office, Market Area, and Industry Position
Table 40. Curium Pharma Nuclear Radiopharmaceutical Models, Specifications, and Application
Table 41. Curium Pharma Nuclear Radiopharmaceutical Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Curium Pharma Company Profile and Main Business
Table 43. Curium Pharma Recent Developments
Table 44. Cardinal Health Company Information, Head Office, Market Area, and Industry Position
Table 45. Cardinal Health Nuclear Radiopharmaceutical Models, Specifications, and Application
Table 46. Cardinal Health Nuclear Radiopharmaceutical Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Cardinal Health Company Profile and Main Business
Table 48. Cardinal Health Recent Developments
Table 49. Bayer Global Company Information, Head Office, Market Area, and Industry Position
Table 50. Bayer Global Nuclear Radiopharmaceutical Models, Specifications, and Application
Table 51. Bayer Global Nuclear Radiopharmaceutical Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Bayer Global Company Profile and Main Business
Table 53. Bayer Global Recent Developments
Table 54. GE Healthcare Company Information, Head Office, Market Area, and Industry Position
Table 55. GE Healthcare Nuclear Radiopharmaceutical Models, Specifications, and Application
Table 56. GE Healthcare Nuclear Radiopharmaceutical Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. GE Healthcare Company Profile and Main Business
Table 58. GE Healthcare Recent Developments
Table 59. Mallinckrodt Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 60. Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Models, Specifications, and Application
Table 61. Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Mallinckrodt Pharmaceuticals Company Profile and Main Business
Table 63. Mallinckrodt Pharmaceuticals Recent Developments
Table 64. Bracco Group Company Information, Head Office, Market Area, and Industry Position
Table 65. Bracco Group Nuclear Radiopharmaceutical Models, Specifications, and Application
Table 66. Bracco Group Nuclear Radiopharmaceutical Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Bracco Group Company Profile and Main Business
Table 68. Bracco Group Recent Developments
Table 69. Advanced Molecular-imaging Solution Company Information, Head Office, Market Area, and Industry Position
Table 70. Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Models, Specifications, and Application
Table 71. Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Advanced Molecular-imaging Solution Company Profile and Main Business
Table 73. Advanced Molecular-imaging Solution Recent Developments
Table 74. China Isotope & Radiation Company Information, Head Office, Market Area, and Industry Position
Table 75. China Isotope & Radiation Nuclear Radiopharmaceutical Models, Specifications, and Application
Table 76. China Isotope & Radiation Nuclear Radiopharmaceutical Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. China Isotope & Radiation Company Profile and Main Business
Table 78. China Isotope & Radiation Recent Developments
Table 79. Ciaeriar Company Information, Head Office, Market Area, and Industry Position
Table 80. Ciaeriar Nuclear Radiopharmaceutical Models, Specifications, and Application
Table 81. Ciaeriar Nuclear Radiopharmaceutical Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Ciaeriar Company Profile and Main Business
Table 83. Ciaeriar Recent Developments
Table 84. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Company Information, Head Office, Market Area, and Industry Position
Table 85. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Models, Specifications, and Application
Table 86. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Company Profile and Main Business
Table 88. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Recent Developments
List of Figures
Figure 1. Nuclear Radiopharmaceutical Picture
Figure 2. Global Nuclear Radiopharmaceutical Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Nuclear Radiopharmaceutical Sales Quantity, (Units) & (2018-2029)
Figure 4. Global Nuclear Radiopharmaceutical Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Nuclear Radiopharmaceutical Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Nuclear Radiopharmaceutical Sales Quantity (Units) & (2018-2029)
Figure 7. China Nuclear Radiopharmaceutical Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Nuclear Radiopharmaceutical Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Nuclear Radiopharmaceutical Market Share of Global, 2018-2029
Figure 10. Global Nuclear Radiopharmaceutical Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Nuclear Radiopharmaceutical Key Participants, Market Share, 2022
Figure 12. Global Nuclear Radiopharmaceutical Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Nuclear Radiopharmaceutical Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Nuclear Radiopharmaceutical Production Market Share & Forecast by Region, 2018-2029
Figure 15. Nuclear Radiopharmaceutical Industry Chain
Figure 16. Nuclear Radiopharmaceutical Procurement Model
Figure 17. Nuclear Radiopharmaceutical Sales Model
Figure 18. Nuclear Radiopharmaceutical Sales Channels, Direct Sales, and Distribution
Figure 19. Diagnostic
Figure 20. Therapeutic
Figure 21. By Type, Global Nuclear Radiopharmaceutical Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Nuclear Radiopharmaceutical Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Nuclear Radiopharmaceutical Sales Quantity, 2018-2029, (Units)
Figure 24. By Type, Global Nuclear Radiopharmaceutical Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Nuclear Radiopharmaceutical Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Oncology
Figure 27. Thyroid
Figure 28. Cardiology
Figure 29. Others
Figure 30. By Application, Global Nuclear Radiopharmaceutical Consumption Value, 2018-2029, US$ Million
Figure 31. By Application, Global Nuclear Radiopharmaceutical Consumption Value Market Share, 2018-2029
Figure 32. By Application, Global Nuclear Radiopharmaceutical Sales Quantity, 2018-2029, (Units)
Figure 33. By Application, Global Nuclear Radiopharmaceutical Sales Quantity Market Share, 2018-2029
Figure 34. By Application, Global Nuclear Radiopharmaceutical Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 35. By Region, Global Nuclear Radiopharmaceutical Consumption Value Market Share, 2018-2029
Figure 36. By Region, Global Nuclear Radiopharmaceutical Sales Quantity Market Share, 2018-2029
Figure 37. North America Nuclear Radiopharmaceutical Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 38. By Country, North America Nuclear Radiopharmaceutical Consumption Value Market Share, 2022
Figure 39. Europe Nuclear Radiopharmaceutical Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, Europe Nuclear Radiopharmaceutical Consumption Value Market Share, 2022
Figure 41. Asia Pacific Nuclear Radiopharmaceutical Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country/Region, Asia Pacific Nuclear Radiopharmaceutical Consumption Value Market Share, 2022
Figure 43. South America Nuclear Radiopharmaceutical Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, South America Nuclear Radiopharmaceutical Consumption Value Market Share, 2022
Figure 45. Middle East & Africa Nuclear Radiopharmaceutical Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 46. U.S. Nuclear Radiopharmaceutical Sales Quantity, 2018-2029, (Units)
Figure 47. By Type, U.S. Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 48. By Application, U.S. Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 49. Europe Nuclear Radiopharmaceutical Sales Quantity, 2018-2029, (Units)
Figure 50. By Type, Europe Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 51. By Application, Europe Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 52. China Nuclear Radiopharmaceutical Sales Quantity, 2018-2029, (Units)
Figure 53. By Type, China Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 54. By Application, China Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 55. Japan Nuclear Radiopharmaceutical Sales Quantity, 2018-2029, (Units)
Figure 56. By Type, Japan Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 57. By Application, Japan Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 58. South Korea Nuclear Radiopharmaceutical Sales Quantity, 2018-2029, (Units)
Figure 59. By Type, South Korea Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 60. By Application, South Korea Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 61. Southeast Asia Nuclear Radiopharmaceutical Sales Quantity, 2018-2029, (Units)
Figure 62. By Type, Southeast Asia Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 63. By Application, Southeast Asia Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 64. India Nuclear Radiopharmaceutical Sales Quantity, 2018-2029, (Units)
Figure 65. By Type, India Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 66. By Application, India Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 67. Middle East & Africa Nuclear Radiopharmaceutical Sales Quantity, 2018-2029, (Units)
Figure 68. By Type, Middle East & Africa Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 69. By Application, Middle East & Africa Nuclear Radiopharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 70. Research Methodology
Figure 71. Breakdown of Primary Interviews
Figure 72. Bottom-up and Top-down Approaches
Figure 73. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|